Abstract:As advances in high-resolution single-cell technology shed light on the complex microenvironment of tumors, the focus of clinical strategies has shifted to single-cell phenotypes in stratified subgroups, and targeting tumor immune-associated landscape strategies may enable more precise treatment modalities. With the elucidation of the tumor landscape, immunotherapy has taken off, but its effectiveness has been hampered by immune escape and the resulting immunological-related side effects. As a result, immunotherapy is invariably studied in concert with other therapies in order to safely and effectively stimulate the anticancer immunity. Photodynamic therapy is unsurpassed in filling gaps in current cancer immunotherapy due to its direct cytotoxic effects, tumor vascular system damage, and generation of a powerful immune response. The mutually reinforcing effects of photodynamic therapy and the tumor-associated immune landscape have been well researched over the years, suggesting that photodynamic therapy combined with targeting tumor landscape strategies can become “magic bullet” in antitumor therapy. However, the inability of conventional drug administration to penetrate malignant tissue and the toxicity of normal tissue owing to passive diffusion have limited their clinical application. Delivery systems based on multifunctional nanomaterials with precise controlled drug release can synergize with other therapies, acting as a bridge to photodynamic immunotherapy. The first thorough and current review of PDT synergistic targeting of tumor-associated immune landscapes employing nanomaterials as bridges is provided in this article. The synergistic therapeutic molecular mechanisms of these nanomaterials, as well as the accompanying design methodologies, are elaborated by following the concept of “from bench to clinic”, covering the latest advanced applications of these nanomaterials, issues in clinical translation, and the outlook.

Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy

Photodynamic-based combinatorial cancer therapy strategies: Tuning the properties of nanoplatform according to oncotherapy needs

Nanocomposite‐Based Photodynamic Therapy Strategies for Deep Tumor Treatment

Nanomaterials-based Photosensitizers and Delivery Systems for Photodynamic Cancer Therapy

Hybrid Nanoparticle Composites Applied to Photodynamic Therapy: Strategies and Applications

Nanoparticle-Based Photodynamic Therapy: Current Status and Future Application to Improve Outcomes of Cancer Treatment.

Nanoparticle-based Drug Delivery Systems for Controllable Photodynamic Cancer Therapy.

Nanoparticles as carriers of photosensitizers to improve photodynamic therapy in cancer

Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy

Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies

Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine

Composite Nanomaterials of Conjugated Polymers and Upconversion Nanoparticles for NIR-Triggered Photodynamic/Photothermal Synergistic Cancer Therapy

Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy

Progress on Polymeric Nanoparticles in Photodynamic Therapy for Cancer

Photodynamic Therapy for Cancer: Mechanisms, Photosensitizers, Nanocarriers, and Clinical Studies.

Nanomaterials for combination cancer photothermal therapy

Photodynamic Nanophotosensitizers: Promising Materials for Tumor Theranostics.

Visualized Photodynamic Nanomaterials Activating Tumor-Associated Immune Landscape As a Next-Generation Anticancer Strategy

Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy

Exploration of New Sensitizers for Photodynamic Therapy Targeting Deep Cancer Treatment

Porphyrin-based Nanocomposites for Tumor Photodynamic Therapy